Suppr超能文献

造血细胞移植候选者的肺功能及移植前评估

Pulmonary Function and Pretransplant Evaluation of the Hematopoietic Cell Transplant Candidate.

作者信息

Cheng Guang-Shing

机构信息

Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, D5-360, Seattle, WA 98109-1024, USA; Division of Pulmonary and Critical Care Medicine, University of Washington School of Medicine, 1959 NE Pacific, Campus Box 356522, Seattle, WA 98195-6522, USA.

出版信息

Clin Chest Med. 2017 Jun;38(2):307-316. doi: 10.1016/j.ccm.2016.12.014. Epub 2017 Mar 3.

Abstract

Pretransplant pulmonary function tests provide baseline data by which to reference subsequent respiratory impairment, as well as important prognostic information, for the hematopoietic cell transplant (HCT) recipient. Abnormalities in forced expiratory volume in 1 second and diffusing capacity of carbon monoxide are associated with early respiratory failure and increased all-cause mortality after allogeneic HCT. These parameters have been incorporated into risk assessment calculators that may aid in clinical decision making. This article discusses the clinical implications of pulmonary function parameters and other risk factors for pulmonary complications in the context of evolving allogeneic HCT practice.

摘要

移植前肺功能测试可为造血细胞移植(HCT)受者提供基线数据,以此作为参考后续呼吸功能损害的依据,以及重要的预后信息。一秒用力呼气量和一氧化碳弥散量异常与异基因HCT后的早期呼吸衰竭及全因死亡率增加相关。这些参数已被纳入风险评估计算器,可能有助于临床决策。本文在不断发展的异基因HCT实践背景下,讨论了肺功能参数及其他肺部并发症风险因素的临床意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验